Malaria, Vivax
9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Infections, Malaria
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Artemether + Lumefantrine for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Artemether + Lumefantrine + TAFENOQUINE for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dihydroartemisinin + Piperaquine tetraphosphate for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dihydroartemisinin + Piperaquine tetraphosphate + TAFENOQUINE for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Primaquine for malaria, vivax | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Pvs230D1-EPA/Matrix-M for malaria, vivax | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tafenoquine for malaria, vivax | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| Tafenoquine + chloroquine for malaria, vivax | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tafenoquine succinate for malaria, vivax | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.